145 related articles for article (PubMed ID: 35190616)
1. Design, synthesis and evaluation of novel 2-oxoindoline-based acetohydrazides as antitumor agents.
Dung DTM; Park EJ; Anh DT; Phan DTP; Na IH; Kwon JH; Kang JS; Tung TT; Han SB; Nam NH
Sci Rep; 2022 Feb; 12(1):2886. PubMed ID: 35190616
[TBL] [Abstract][Full Text] [Related]
2. New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity.
Huan LC; Anh DT; Truong BX; Duc PH; Hai PT; Duc-Anh L; Huong LT; Park EJ; Lee HJ; Kang JS; Tran PT; Thanh Hai DT; Kim Oanh DT; Han SB; Nam NH
Chem Biodivers; 2020 Mar; 17(3):e1900670. PubMed ID: 31943757
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Evaluation of Novel (E)-N'-((1-(4-chlorobenzyl)-1H-indol-3-yl)methylene)-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as Antitumor Agents.
Dung DTM; Park EJ; Anh DT; Hai PT; Bao LQ; Ji AY; Kang JS; Tung TT; Han SB; Nam NH
Anticancer Agents Med Chem; 2022; 22(14):2586-2598. PubMed ID: 35040418
[TBL] [Abstract][Full Text] [Related]
4. N'-[(E)-Arylidene]-2-(2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)-acetohydrazides: Synthesis and Evaluation of Caspase Activation Activity and Cytotoxicity.
Huan LC; Truc LC; Phuong CV; Hai PT; Huong LT; Linh NTP; Thuan NT; Park EJ; Choi YJ; Kang JS; Han SB; Nam NH; Tran PT
Chem Biodivers; 2018 Oct; 15(10):e1800322. PubMed ID: 30054973
[TBL] [Abstract][Full Text] [Related]
5. Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design, synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.
Huan LC; Tran PT; Phuong CV; Duc PH; Anh DT; Hai PT; Huong LTT; Thuan NT; Lee HJ; Park EJ; Kang JS; Linh NP; Hieu TT; Oanh DTK; Han SB; Nam NH
Bioorg Chem; 2019 Nov; 92():103202. PubMed ID: 31479984
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents.
Dung DTM; Park EJ; Anh DT; Hai PT; Huy LD; Jun HW; Kwon JH; Young Ji A; Kang JS; Tung TT; Dung PTP; Han SB; Nam NH
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100216. PubMed ID: 34674294
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of novel
Huan LC; Anh DT; Hai PT; Anh LD; Park EJ; Ji AY; Kang JS; Dung DTM; Oanh DTK; Tung TT; Hai DTT; Han SB; Nam NH
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1854-1865. PubMed ID: 32981382
[TBL] [Abstract][Full Text] [Related]
8. (E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.
Huan LC; Phuong CV; Truc LC; Thanh VN; Pham-The H; Huong LT; Thuan NT; Park EJ; Ji AY; Kang JS; Han SB; Tran PT; Nam NH
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):465-478. PubMed ID: 30734614
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-tumor evaluation of novel hydrazide and hydrazide-hydrazone derivatives.
Wardakhan WW; El-Sayed NN; Mohareb RM
Acta Pharm; 2013 Mar; 63(1):45-57. PubMed ID: 23482312
[TBL] [Abstract][Full Text] [Related]
10. Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay.
Sirisoma N; Pervin A; Drewe J; Tseng B; Cai SX
Bioorg Med Chem Lett; 2009 May; 19(10):2710-3. PubMed ID: 19369076
[TBL] [Abstract][Full Text] [Related]
11. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.
Ma J; Chen D; Lu K; Wang L; Han X; Zhao Y; Gong P
Eur J Med Chem; 2014 Oct; 86():257-69. PubMed ID: 25171780
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3'-methoxy-4'-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents.
Senwar KR; Reddy TS; Thummuri D; Sharma P; Naidu VG; Srinivasulu G; Shankaraiah N
Eur J Med Chem; 2016 Aug; 118():34-46. PubMed ID: 27128173
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer and antioxidant activities of some novel N-(benzo[d]oxazol-2-yl)-2-(7- or 5-substituted-2-oxoindolin-3-ylidene) hydrazinecarboxamide derivatives.
Gudipati R; Anreddy RN; Manda S
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):813-8. PubMed ID: 21476831
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines.
Lan TT; Anh DT; Pham-The H; Dung DTM; Park EJ; Jang SD; Kwon JH; Kang JS; Thuan NT; Han SB; Nam NH
Chem Biodivers; 2020 Jul; 17(7):e2000290. PubMed ID: 32356584
[TBL] [Abstract][Full Text] [Related]
17. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
Cheng C; Yun F; He J; Ullah S; Yuan Q
Eur J Med Chem; 2019 Jul; 173():185-202. PubMed ID: 31003060
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, pharmacological screening and computational analysis of some 2-(1H-Indol-3-yl)-N'-[(un)substituted phenylmethylidene] acetohydrazides and 2-(1H-Indol-3-yl)-N'-[(un)substituted benzoyl/2-thienylcarbonyl]acetohydrazides.
Rubab K; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Ain Q; Ahmad I; Lodhi MA; Ghufran M; Shahid M; Fatima H
Pak J Pharm Sci; 2017 Jul; 30(4):1263-1274. PubMed ID: 29039324
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents.
Hu H; Dong Y; Li M; Wang R; Zhang X; Gong P; Zhao Y
Bioorg Chem; 2019 Sep; 90():103086. PubMed ID: 31280016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
